Anti-arrhythmia drugs--administration and effectiveness
Odenthal, H.J.; Wiechmann, H.W.
Medizinische Monatsschrift für Pharmazeuten 10(12): 375-380
1987
ISSN/ISBN: 0342-9601 PMID: 3325785 Document Number: 298610
Document emailed within 1 workday
Related Documents
Tuna, J.L. 1992: Classification of anti-arrhythmia drugs and their mechanism of action. Iatrogeny of anti-arrhythmia agents Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 11(4): 385-386Chiche, P.; Domengie, B.; Benaim, R.; Calvo, G. 1975: New anti-arrhythmia drugs Semaine des Hopitaux. Therapeutique 51(10): 529-533
Hohnloser, S.H.; Zabel, M. 1991: Anti-arrhythmia drugs in geriatric patients Fortschritte der Medizin 109(25): 492-495
Sokolov, S.F.; Golitsyn, S.P.; Malakhov, V.I.; Bankuzov, V.A.; Koltunova, M.I.; Golitsyn, L.S. 1990: The anti-arrhythmia activity and effect on the heart conduction system of the new anti-arrhythmia preparation bonnecor Farmakologiia i Toksikologiia 53(3): 57-60
Anshelevich, I.V.; Sorokina, T.A.; Bekere, F.A.; Slaĭdyn', A.K.; Beer, E.T. 1980: Effectiveness of anti-arrhythmia agents in atrial fibrillation paroxysms Klinicheskaia Meditsina 58(6): 43-46
Kotliarov, A.A.; Smirnov, L.D.; Smirnova, L.E.; Kurkina, N.V.; Balykova, L.A.; Kariakina, T.N. 2002: Combined administration of mexidol and anti-arrhythmia agents Eksperimental'naia i Klinicheskaia Farmakologiia 65(5): 31-34
Ferrari, M.; Malini, P.L.; Padrini, R.; Costa, F.V.; Gobbato, S.; Ambrosioni, E. 1980: Clinical value of the determination of anti-arrhythmia drugs in the plasma Bollettino Della Societa Italiana di Cardiologia Suppl: 91-100
Jaillon, P.; Simon, T. 1992: Ventricular pro-arrhythmic effects of anti-arrhythmia drugs Therapie 47(3): 187-192
Zehender, M.; Geibel, A.; Hust, M.; Hohnloser, S.; Meinertz, T.; Just, H. 1987: Anti-arrhythmia effectiveness and tolerance of retard in comparison with standard mexiletine Zeitschrift für Kardiologie 76(8): 501-506
Zrenner, B.; Koller, B.; Rudolph, W. 1990: Can sudden cardiac death be prevented by treatment with anti-arrhythmia drugs? Herz 15(2): 90-102
Honerjäger, P.; Schmidt, G. 1993: Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 48(9): 425-429
Storozhuk, B.G. 1985: Anti-arrhythmia activity and side effects of various anti-arrhythmia agents Vrachebnoe Delo 3: 41-44
Abdalla, A.; Mazur, N.A.; Shestakova, N.V.; Sumarokov, A.B. 1990: Arrhythmogenic effect of anti-arrhythmia drugs: incidence, possible mechanisms and therapeutic tactics Kardiologiia 30(1): 95-100
Burhorn, D.; Siegers, C.P.; Diederich, K.W. 1975: Relationship between anti-arrhythmia effect and pharmacological data of Brufacaine in parenteral and oral administration in man Verhandlungen der Deutschen Gesellschaft für Innere Medizin 81: 187-190
Witkowska, M. 1982: Clinical pharmacology of anti-arrhythmia agents. III. Drugs blocking beta adrenergic receptors Kardiologia Polska 25(2): 147-161
Mazurowa, A.; Szadowska, A.; Szmigielski, A. 1972: Combined action on the heart of beta adrenergic blocking agents and anti-arrhythmia drugs Kardiologia Polska 15(2): 167-175
Steinbeck, G. 1992: Which patient with sustained ventricular tachycardia is suited for long-term therapy with anti-arrhythmia drugs? Zeitschrift für die Gesamte Innere Medizin und ihre Grenzgebiete 47(5): 195-201
Leclercq, J.F.; Attuel, P.; Milosevic, D.; Coumel, P. 1979: Quantitative evaluation of the efficacy of anti-arrhythmia agents in chronic ventricular arrhythmia Acta Cardiologica 34(1): 35-50
Nakamura, H. 2004: Recent progress in molecular etiology of arrhythmia and anti-arrhythmia drug therapy Masui. Japanese Journal of Anesthesiology 53 Suppl: S81-S90
Bracchetti, D.; Mantovani, B.; Naccarella, F.; Lombardi, G.; Palmieri, M. 1980: Evaluation of the efficacy of anti-arrhythmia agents in hyperkinetic ventricular arrhythmia Bollettino Della Societa Italiana di Cardiologia Suppl: 117-123